698 / 1082
S682
ESTRO 36 2017
_______________________________________________________________________________________________
Thirty-nine pts treated from May 2015 to February 2016
were included in this analysis. The median age was 64
years [range 44-77years]; Male-Female ratio was 2.2.
Clinical involvement of mesorectal fascia was detected in
18
pts
(46%).
CTV2 included always presacral space and internal iliac
nodes, in 30 pts (77%) and in 4 pts (10%) the obturator
nodes and the external iliac nodes were added,
respectively. 5 pts received CT in the pre-surgical
pause. 38 pts received a Total Mesorectal Excision surgery
(69% Anterior Resection and 26% Abdominal-Perineal
Resection), in 2 pts (5%) a WW approach was preferred.
Adjuvant CT was administered to 18 pts. The radiation
prescribed dose was entirely delivered in all pts. GI
toxicity was recorded in 31 pts (79%): diarrhea and
proctitis were most detected. Four cases of grade 3 GI
toxicities were registered (6% of all GI toxicities). GU and
HE toxicities were less frequent: non infective cystitis (13
pts) and neutropenia (6 pts) were observed. However,
none of them presented a toxicity grade≥ 3.
About CT, 8 pts (20%) received less than 4 cycles of
concomitant CT because of HE or GI toxicity. pCR was
achieved in 10 pts (26%). TRG grade 1 2 3 and 4 was
recorded in 11 (28%), 8 (20.5%), 13 (33%) and 5 (13%),
respectively. At the median follow-up of 18 weeks the
local control, the disease-free survival and the overall
survival rates were 100%, 92% and 97%, respectively.
Conclusion
The SIB/VMAT schedule is well tolerate in LARC. The
toxicity was well manageable and the prescribed dose is
delivered. Despite the few numbers of patients the rate of
pCR is promising. Longer follow-up is required for survival
outcomes.
EP-1282 Clinical and pathological prognostic factors in
locally advanced rectal cancer (larc)
S. Montrone
1
, A. Sainato
1
, R. Morganti
2
, C. Vivaldi
3
, C.
Laliscia
1
, B. Manfredi
1
, G. Coraggio
1
, M. Cantarella
1
, G.
Musettini
3
, D. Delishaj
1
, E. Lombardo
1
, A. Cristaudo
1
, F.
Orlandi
1
, G. Masi
3
, P. Buccianti
4
, A. Falcone
3
, F.
Pasqualetti
1
, F. Paiar
1
1
OSPEDALE SANTA CHIARA, Radiotherapy, PISA, Italy
2
OSPEDALE SANTA CHIARA, Oncology- Biostatistical
Consulting, PISA, Italy
3
OSPEDALE SANTA CHIARA, Oncology, PISA, Italy
4
OSPEDALE CISANELLO, Colon-rectal Surgery, PISA, Italy
Purpose or Objective
Colorectal cancer is the most common gastrointestinal
malignancy. More than half of rectal cancer patients (pts)
have a LARC at diagnosis and preoperative RT-CT followed
by total mesorectal excision (TME) is the standard of cure
in these pts. Many studies have analyzed clinical and
pathological parameters that could be considered as
prognostic factors in pts with rectal cancer. This study aim
to identify prognostic factors related to OS and DFS in pts
affected by LARC and treated in Pisa University Hospital
between January 2008 and April 2014.
Material and Methods
We analyzed retrospectively the data of 119 pts affected
by LARC treated with neoadjuvant RT-CT (50.4 Gy in 28 FF
+ capecitabine 1650 mg/mq/day) followed by TME-
surgery. In order to identify prognostic factors, we
analyzed T and N characteristics at diagnosis and at
restaging (before surgery) and their variations (based on
MR-images). We also analyzed age, sex and pathological
characteristics (surgical approach, ypT, ypN, number of
nodes removed, nodal ratio considered as N+/Nresected,
histological mucinous aspect, grading, margins, Quirke
grade andDworak’s tumor regression).
Results
All pts completed planned RT-CT. The OS at 2 and 5 years
was 97,3% and 88,5%, respectively; 2 and 5 years DFS was
91,5% and 77,5%, respectively. In the multivariate
analysis the statistically significant prognostic factors
related to DFS were: T-volume (p= 0,046), number of
involved quadrants (p= 0,011), distance between T and
mesorectal fascia (p= 0,015), pT (p= 0,001), pN (p<0,001),
nodal ratio (p<0,0001) and TRG (p= 0,001). Regard to OS,
the statistically significant prognostic factors were:
number of involved quadrants (p= 0,011), pN (p= 0,009),
number of resected nodes (p= 0,042) and nodal ratio (p=
0,002).
Conclusion
Analyzing our data, we could conclude that clinical T-
parameters, pathological T stage and pathological N-
parameters are strongly related to an higher incidence of
local and distant relapses (DFS). Regard to OS, clinical T-
parameters and pathological N-parameters are
singnificantly correlated, while pathological T stage does
not seem to have a role as prognostic factor. A better
knowledge of these factors related to local and distant
relapses will be necessary to decide whether intensify
local or systemic treatments.
EP-1283 Short Course Radiation Therapy For Locally
Advanced Rectal Cancer
J. Casalta Lopes
1
, A. Ponte
1
, I. Nobre-Góis
1
, T. Teixeira
1
,
M.R. Silva
2
, M. Borrego
1
1
Centro Hospitalar e Universitário de Coimbra, Radiation
Oncology, Coimbra, Portugal
2
Centro Hospitalar e Universitário de Coimbra,
Pathology, Coimbra, Portugal
Purpose or Objective
v
Locally advanced rectal carcinoma (LARC)v is usually
treated with radiotherapy (RT) followed by svurgery. One
of the schemes is short course RT (SC: 25Gy / v5 fractions
/ 1 week) historically followed by immedviate surgery.
Studies show that a longer interval between SC-RT and
surgery may increase downstaging, with the acceptance of